Pharvaris studies of rare disease drug put on hold by FDA

Submitted by admin on August 22, 2022 - 8:12pm

Source:

BioPharma Dive

News Tags:

Pharvaris

FDA

hereditary angiodema

HAE

PHA121

Headline:

Pharvaris studies of rare disease drug put on hold by FDA

snippet:

Shares in Pharvaris plunged Monday after the Swiss biotechnology company revealed the Food and Drug Administration has suspended testing of its most advanced drug for the rare disease hereditary angioedema.

Search form

You are here

Pharvaris studies of rare disease drug put on hold by FDA

Pharvaris studies of rare disease drug put on hold by FDA